Skip to main content
. 2022 Mar 29;20(3):e07209. doi: 10.2903/j.efsa.2022.7209

Table 6.

Occurrence of resistance (%) to selected antimicrobials in Campylobacter jejuni and C. coli from carcases, fresh meat and meat preparation from broilers, using harmonised ECOFFs, in 2019 and 2020 (only MSs)

Species Categories Year Number of isolate Reporting countries (N) GEN STR CIP ERY TET CIP/ERY CS
C. jejuni Broiler carcases 2019 70 HR, LU, NL, PT, RO (5) 0.0 7.2 90.0 0.0 42.9 0.0 8.6
2020 361 HR, DE, NL, RO (4) 0.0 23.8 82.8 0.5 57.6 0.3 13.85
Fresh broiler meat 2019 398 AT, BE, DK, LU, NL, PT (6) 0.0 8.3 68.6 0.25 44.1 0.25 30.10
2020 343 AT, BE, DE, LU, NL (5) 0.0 22.2 74.9 0.0 58.6 0.0 21.9
Broiler meat preparations 2019 53 BE, LU, NL (3) 0.0 15.1 64.2 0.0 52.8 0.0 28.3
C. coli Fresh broiler meat 2020 99 AT, BE, DE, LU, NL (5) 1.0 16.2 84.8 10.1 67.7 10.1 5.05
Broiler carcases 2020 76 DE, LU, NL, RO (4) 2.6 7.9 71.0 10.5 57.9 10.5 21.05

GEN: gentamicin, STR: streptomycin, NAL: nalidixic acid, CIP: ciprofloxacin, ERY: erythromycin, TET: tetracycline, CIP/ERY: combined ‘microbiological’ resistance to ciprofloxacin and erythromycin, CS: complete susceptibility to the four antimicrobial classes (ciprofloxacin/nalidixic acid, erythromycin, tetracycline and gentamicin/streptomycin), N: Total number of reporting Member States (MSs).